Skip to main content

Solenis sale creates water treatment giant

7th July 2021

Submitted by:

Andrew Warmington

As rumoured last month, BASF and private equity investor Clayton, Dubilier & Rice (CD&R) have exited their joint ownership of paper and water treatment chemicals company Solenis, by selling it to Platinum Equity. Solenis will be merged with Platinum’s existing subsidiary Sigura, creating a player in water treatment with $3.5 billion/year in sales.

The transaction implies an enterprise value of $5.25 billion for Solenis, including net debt, while the merger gives a combined transaction value of about $6.5 billion. Both should be completed by the end of 2021, subject to regulatory approval and customary closing conditions.

Delaware-based Solenis is active across 120 countries in five continents, with over 5,200 employees and 41 manufacturing facilities. CD&R acquired it from Ashland in 2014. It was merged with BASF’s paper-wet-end and water-chemicals business in a 51-49 joint venture in 2019, the same year that Platinum acquired Sigura.

Platinum managing director Todd Golditch described the two firms as “highly complementary businesses and a fantastic fit with very little product or customer overlap”. Both, he added “will benefit from increased scale and end-market diversification” and further M&A opportunities will be sough.

Sigura makes water care products for commercial pool and spa applications as well as industrial markets, while Solenis has two main businesses: Consumer Solutions, in the consumer and food packaging, graphic paper, and tissue and towel markets; and Industrial Solutions, in the core water treatment and wastewater markets.

Solenis CEO John Panichella will lead the combined company and following integration. Sigura CEO Robert Baird will lead a new Pool Solutions division. BASF said that it will continue to supply products to or source them from Solenis under existing mid- to long-term agreements.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington